Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year Enduring

NATF is pleased to partner with ScientiaCME to offer online continuing medical education programs. Please log in on the ScientiaCME website to enroll in courses and claim credits. If you don’t currently have a ScientiaCME login, you can sign up here.


Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year focuses on key lessons learned during the COVID-19 pandemic, including how mRNA vaccine technology may be leveraged in cardiovascular medicine, what we know about thromboinflammation in COVID-19, the potential effects of long COVID syndrome on our patients and the healthcare system, and how clinicians can begin to address both the consequences of delayed cardiac care and the myriad healthcare inequities that have been uncovered over the last 18 months.

The content of this internet enduring material activity was originally presented as part of a live event. Learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit. 


This program has been designed for physicians, nurse practitioners, physician assistants, pharmacists, and other clinicians specializing in cardiology, family medicine, hematology, hospital medicine, infectious disease, internal medicine, pulmonology and critical care, rheumatology, and vascular medicine.


By the end of the session the participant will be able to:

  • Recall how mRNA technology used to develop vaccines for COVID-19 can be leveraged in cardiovascular medicine
  • Explain how the link between inflammation and thrombosis that has characterized COVID-19 has implications for other aspects of medicine
  • Describe long COVID syndrome and how medicine will handle this complication of COVID-19
  • Summarize trends in cardiovascular care utilization during the COVID-19 pandemic and implications for future burden of disease and formulate a patient care plan based on that information
  • Recognize healthcare disparities exposed by COVID-19 and how medicine needs to make changes for the health of all our communities


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Physicians: ScientiaCME designates these internet enduring material activities for a maximum of 2.25 AMA PRA Category 1 Credit(s)™ toward the AMA Physician’s Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.  ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Pharmacists: ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ScientiaCME designates the following activity for a maximum of 2.25 contact hour(s) (0.225 CEUs). Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire group of presentations and complete the course evaluation to receive continuing pharmacy education credit. ACPE# 0574-9999-22-012-H01-P

This is a Knowledge (K)-type activity.

You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

The CPE statements of credit contain information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation in this activity is free.

The activity is being provided without commercial support.

RELEASE DATE: May 4, 2022 — EXPIRATION DATE: May 3, 2023


President’s Perspective & Welcome
Samuel Z. Goldhaber, MD – Harvard Medical School

Riding the Wave of mRNA Vaccine Technology: Applications in Cardiovascular Medicine
Kathryn E. Stephenson, MD, MPH – Assistant Professor of Medicine, Harvard Medical School Staff Physician, Division of Infectious Diseases, Beth Israel Deaconess Medical Center

Thromboinflammation in COVID-19: Lessons in Thrombosis for a Post-Pandemic World
Peter Libby, MD – Mallinckrodt Professor of Medicine, Harvard Medical School
Cardiovascular Specialist, Brigham and Women’s Hospital

Long COVID Syndrome: A Pandemic After the Pandemic?
Kristin Englund, MD, MLS – Assistant Professor, Cleveland Clinic Lerner College of Medicine of CWRU Staff Physician, Cleveland Clinic

Missed and Delayed Cardiovascular Care during the COVID-19 Pandemic: Consequences for Population Health
Karen Joynt Maddox, MD, MPH – Associate Professor, Washington University School of Medicine Cardiologist, Barnes-Jewish Hospital

Healthcare Disparities Exposed: How COVID-19 Showed Us That We Need to Do Better
Cassandra Pierre, MD, MSc – Assistant Professor of Medicine, Boston University School of Medicine Associate Hospital Epidemiologist, Boston Medical Center

Panel Discussion


Samuel Z. Goldhaber, MD: Research Grants – Alexion, Amgen, Bayer, Bristol-Myers Squibb, Pfizer, BSC, Janssen; Consultant – Agile, Bayer, Pfizer

Peter Libby, MD: Research Grants – Novartis; Consultant – Amgen, AstraZeneca, Baim Institute, Beren Therapeutics, Esperion Therapeutics, Genentech, Kancera, Kowa Pharmaceuticals, Medimmune, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi-Regeneron; Scientific Advisory Board – Amgen, Caristo Diagnostics, Cartesian Therapeutics, Corvidia Therapeutics, CSL Behring, DalCor Pharmaceuticals, Dewpoint Therapeutics, Kancera, Kowa Pharmaceuticals, Olatee Therapeutics, Medimmune, Novartis, PlaqueTec, XBiotech, Inc.

Karen Joynt Maddox, MD, MPH: Health Policy Advocate Committee – Centene Corporation

Gregory Piazza, MD, MS: Research Grants – Alexion, Amgen, Bayer, BMS/Pfizer, BSC, Janssen

Individuals with no conflicts of interest to disclose: 

  • Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME
  • Kristin Englund, MD, MLS
  • Cassandra Pierre, MD, MPH
  • Kathryn E. Stephenson, MD, MPH


  • Read the learning objectives above.
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Take the post-test.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately. 



  • Windows 7 or above
  • Internet Explorer 8
  • *Adobe Acrobat Reader


  • Safari or Chrome or Firefox
  • *Adobe Acrobat Reader
  • Internet Explorer is not supported on Macintosh

*Required to view Printable PDF Version

Related Articles